Chromosomal aberrations induced in mice bone marrow by treating with cisplatin and irradiation

Citation
F. Wurschmidt et al., Chromosomal aberrations induced in mice bone marrow by treating with cisplatin and irradiation, STRAH ONKOL, 176(7), 2000, pp. 319-323
Citations number
13
Categorie Soggetti
Oncology
Journal title
STRAHLENTHERAPIE UND ONKOLOGIE
ISSN journal
01797158 → ACNP
Volume
176
Issue
7
Year of publication
2000
Pages
319 - 323
Database
ISI
SICI code
0179-7158(200007)176:7<319:CAIIMB>2.0.ZU;2-O
Abstract
Background: The aim of this study was to quantify the combined effect of ci splatin and radiation on chromosomal damage with emphasis on the time inter val between cisplatin and radiation. Methods and Materials: Bone marrow of female NMRI-nu(+) mice was taken as a model system for a highly proliferative tissue irradiated with cobalt-60 ( 1 to 4 Gy). Cisplatin was injected intraperitoneally tip) at 1.1 to 36 mg/k g. Cisplatin was given at various time intervals before and after radiation . Bone marrow and metaphases were prepared according to standard procedures . Results: The percentage of aberrant metaphases after radiation or cisplatin alone increased in a dose-dependent manner (sigmoidal dose-response curve) . Combining both modalities led to additive values at all time points for t he percentage of aberrant metaphases. Borderline significant (p < 0.05) sup raadditive effects were found 2 hours before or 1 hour after irradiation. H owever, a supraadditive percentage of aberrant chromosomes was found only a t 2 or 1.5 hours with cisplatin before irradiation indicating the dependenc e of supraadditivity on the chosen parameter. Conclusion: It is doubtful to expect a true supraadditive or "radiosensitiz ing'` effect, e.g. in the clinical setting from combined treatment with cis platin and radiation. Rather, cisplatin might act as an independent cytotox ic agent.